SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Evommune, Inc. released an EX-99.1 filing containing a corporate presentation for September 2026, outlining pipeline progress for assets including EVO...
USA TODAY Co. appointed Babbel CEO Tim Allen to its Board of Directors, adding digital innovation expertise to its leadership team. The move is expect...
Aethlon Medical Inc. amended James Frakes' employment agreement to ensure Change in Control severance benefits are paid in a single lump sum. This cha...
Otis Worldwide Chair, CEO and President Judith Marks will retire from the company and board upon the appointment of a successor, expected in 2027. Sh...
Vera Bradley reported a 1.1% increase in consolidated net revenues to $71.6 million, with net income turning positive, as it continues its five-pillar...
The board approved the separation of Corteva's seed operating segment into a new publicly traded company, Vylor, with a dividend of one Vylor share fo...
RB Global Inc. announced an increase to its share repurchase program from $500 million to $1 billion. The company recently repurchased over 5 million ...
LB Pharmaceuticals named neuropsychiatry expert Dr. Susan G. Kozauer as Chief Medical Officer, bolstering leadership ahead of key Phase 3 schizophreni...
NextTrip’s JOURNY TV will premiere the first original series "I DO: In Destination" on October 4 and 5, 2026, advancing the company's content-to-comme...
Sadot Group Inc. announced Dr. Roy K. Zeigler appointed as new Chief Executive Officer effective immediately, succeeding the founder....
Cheetah Net Supply Chain Service Inc. entered into a definitive agreement to acquire JoyPak Supply LLC from Sellers Newland and Redwing for $788,000, ...
Aspen Aerogels Inc. released its September 2026 investor presentation outlining its financial outlook, excluding uncertainty from forward-looking stat...
Lindblad Expeditions agreed to acquire a majority interest in White Desert, PNR Airways, and Echo Charlie. The deal includes consideration adjustments...
Quantum X Labs appoints former Mossad Director Yossi Cohen to its Scientific Advisory Board to strengthen quantum computing and commercialization effo...
The company announced plans to expand into Georgia and Tennessee following the recent enactment of state laws establishing frameworks for certain stem...
BlossomHill Therapeutics presented encouraging efficacy data from its Phase 1/2 SOLARA trial, demonstrating a 45% objective response rate from BH-3064...
Axon intends to sell $1.0 billion of zero-coupon convertible notes due 2031, using proceeds for general corporate purposes, including growth and acqui...
Driven Brands Holdings established a long-term debt target of 2-3x and approved a $100M share repurchase program. The company previously achieved its ...
FibroBiologics issued a warrant granting the holder the right to subscribe for shares until September 2026 after a Securities Purchase Agreement. This...
The FDA confirmed the pivotal study design, protocols for continued dosing, and co-primary endpoints for RP-A501, including a 12-patient efficacy popu...